28506 Federal Register / Vol. 74, No. 114 / Tuesday, June 16, 2009 / Notices 

EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST ($ THOUSANDS) 

Cost component Total cost Annualized 

cost 

Project Development ............................................................................................................................................... $3,099 $1,550 

Data Collection Activities ......................................................................................................................................... 7,230 3,615 

Data Processing and Analysis ................................................................................................................................. 7,230 3,615 

Project Management ................................................................................................................................................ 2,066 1,033 

Overhead ................................................................................................................................................................. 1,033 517 

Total .................................................................................................................................................................. 20,658 10,329 

Note: Components may not sum to Total 

due to rounding. 

Request for Comments 

In accordance with the above-cited 

Paperwork Reduction Act legislation, 

comments on AHRQ’s information 

collection are requested with regard to 

any of the following: (a) Whether the 

proposed collection of information is 

necessary for the proper performance of 

AHRQ health care research, quality 

improvement and information 

dissemination functions, including 

whether the information will have 

practical utility; (b) the accuracy of 

AHRQ’s estimate of burden (including 

hours and costs) of the proposed 

collection(s) of information; (c) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(d) ways to minimize the burden of the 

collection of information upon the 

respondents, including the use of 

automated collection techniques or 

other forms of information technology. 

Comments submitted in response to 

this notice will be summarized and 

included in the Agency’s subsequent 

request for OMB approval of the 

proposed information collection. All 

comments will become a matter of 

public record. 

Dated: June 4, 2009. 

Carolyn M. Clancy, 

Director. 

[FR Doc. E9–14079 Filed 6–15–09; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Emergency 

Review; Comment Request; NIH NCI 

Clinical Trials Reporting Program 

(CTRP) Database (NCI) 

SUMMARY: In accordance with Section 

3507(j) of the Paperwork Reduction Act 

of 1995, the National Cancer Institute 

(NCI), the National Institutes of Health 

(NIH), has submitted to the Office of 

Management and Budget (OMB) a 

request to Emergency review and 

approve the information collection by 

July 1, 2009. Given the long term nature 

of this project and the Recovery Act 

timelines, the NCI has requested 

approval to conduct emergency 

processing of information collections 

pursuant to 5 CFR 1320.13. NIH cannot 

reasonably comply with the normal 

clearance procedures for information 

collection, because the use of regular 

procedures would delay the collection 

and hinder the agency in accomplishing 

its mission and meeting new statutory 

requirements, to the detriment of the 

public good. The NIH may not conduct 

or sponsor, and the respondent is not 

required to respond to, an information 

collection that has been extended, 

revised, or implemented on or after 

October 1, 1995, unless it displays a 

currently valid OMB control number. 

Proposed Collection 

Title: NIH NCI Clinical Trials 

Reporting Program (CTRP) Database. 

Type of Information Collection 

Request: Emergency. 

Need and Use of Information 

Collection: The NCI is developing an 

electronic resource, the NCI Clinical 

Trials Reporting Program (CTRP) 

Database, to serve as a single, definitive 

source of information about all NCIsupported clinical research, thereby 

enabling the NCI to execute its mission 

to reduce the burden of cancer and to 

ensure an optimal return on the nation’s 

investment in cancer clinical research. 

Information will be submitted by 

clinical research administrators as 

designees of clinical investigators who 

conduct NCI-supported clinical 

research. Deployment and extension of 

the CTRP Database, which will allow 

the NCI to consolidate reporting, 

aggregate information and reduce 

redundant submissions, is an 

infrastructure development project that 

will be enabled by public funds 

expended pursuant to the American 

Recovery and Reinvestment Act of 2009, 

Public Law 111–5 (‘‘Recovery Act’’). 

This information collection adheres to 

The Public Health Service Act, Section 

407(a)(4) (codified at 42 U.S.C. 285a– 

2(a)(2)(D)), which authorizes and 

requires the NCI to collect, analyze and 

disseminate all data useful in the 

prevention, diagnosis, and treatment of 

cancer, including the establishment of 

an international cancer research data 

bank to collect, catalog, store, and 

disseminate insofar as feasible the 

results of cancer research undertaken in 

any country for the use of any person 

involved in cancer research in any 

country. 

Frequency of Response: Once per 

initial trial registration; four 

amendments per trial annually. 

Affected Public: Individuals, business 

and other for-profits, and not-for-profit 

institutions. 

Type of Respondents: Clinical 

research administrators on behalf of 

clinical investigators. The annual 

reporting burden is estimated at 33,000 

hours (see Table below). 

There are no Capital Costs, Operating 

Costs, and/or Maintenance Costs to 

report. 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 74, No. 114 / Tuesday, June 16, 2009 / Notices 28507 

ESTIMATES OF ANNUAL BURDEN HOURS

Type of 

respondents Survey instrument Number of respondents 

Frequency of 

response 

Average time 

per response 

(hours) 

Annual 

burden hours 

Clinical Trials ..................................... Initial Registration ............................. 5,500 1 2.0 11,000 

Amendment ...................................... 5,500 4 1.0 22,000 

Total ........................................... ........................................................... ........................ ........................ ........................ 33,000 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the 

Attention: NIH Desk Officer, Office of 

Management and Budget, at 

OIRA_submission@omb.eop.gov or by 

fax to 202–395–6974. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact John 

Speakman, Associate Director for 

Clinical Trials Products and Programs, 

Center for Biomedical Informatics and 

Information Technology, National 

Cancer Institute, NIH, DHHS, 2115 E. 

Jefferson Street, Suite 6000, Rockville, 

MD 20892 or call non-toll-free number 

301–451–8786 or e-mail your request, 

including your address to: 

john.speakman@nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 15 days of the date of 

this publication. 

Dated: June 9, 2009. 

Vivian Horovitch-Kelley, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. E9–14089 Filed 6–15–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office of Refugee Resettlement; 

Single-Source Program Expansion 

Supplement to the Lutheran Social 

Services of South Dakota (LSS–SD) 

Under the South Dakota Wilson-Fish 

Program, Award 

AGENCY: Office of Refugee Resettlement, 

ACF, HHS. 

ACTION: Notice to award a single-Source 

program expansion supplement to the 

Lutheran Social Services of South 

Dakota (LSS–SD) under the South 

Dakota Wilson-Fish Program. 

CFDA Number: 93.583. 

Legislative Authority: The Refugee Act 

of 1980 as amended, Wilson-Fish 

Amendment, 8 U.S.C. 1522(e)(7); 

section 412(e)(7)(A) of the Immigration 

and Nationality Act. 

Amount of Award: $125,000. 

Project Period: 09/30/2007–09/29/ 

2010 

Justification for the Exception to 

Competition: The Wilson-Fish program 

is an alternative to the traditional Stateadministered refugee assistance program 

for providing integrated assistance and 

services to refugees, asylees, Amerasian 

Immigrants, Cuban and Haitian 

Entrants, Trafficking Victims and Iraqi/ 

Afghani SIV’s. South Dakota is one of 12 

sites that has chosen this alternative 

approach. 

The supplemental funds will allow 

the grantee, LSS–SD, located in Sioux 

Falls, SD, to provide refugee cash 

assistance through the end of this fiscal 

year to eligible refugees (and others 

eligible for refugee benefits) under the 

South Dakota Wilson-Fish Program. 

The primary reason for the grantee’s 

supplemental request is a higher 

number of arrivals than anticipated 

when the grantee’s budget was 

submitted and approved last year. The 

Refugee Act of 1980 mandates that the 

Office of Refugee Resettlement (ORR) 

reimburse States and Wilson-Fish 

projects for the costs of cash and 

medical assistance for newly arriving 

refugees. Since 1991, ORR has 

reimbursed States and Wilson-Fish 

agencies for providing cash and medical 

assistance to eligible individuals during 

their first eight months in the United 

States. Hence, the supplement is 

consistent with the purposes of the 

Wilson-Fish Program, the Refugee Act of 

1980, and ORR policy. 

CONTACT FOR FURTHER INFORMATION: Carl 

Rubenstein, Wilson-Fish Program 

Manager, Office of Refugee 

Resettlement, Aerospace Building, 8th 

Floor West, 901 D Street, SW., 

Washington, DC 20447. Telephone: 

202–205–5933, E-mail: 

crubenstein@acf.hhs.gov. 

Dated: 06/04/2009. 

David H. Siegel, 

Acting Director, Office of Refugee 

Resettlement. 

[FR Doc. E9–14140 Filed 6–15–09; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Current List of Laboratories Which 

Meet Minimum Standards To Engage in 

Urine Drug Testing for Federal 

Agencies 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services (HHS) notifies Federal 

agencies of the laboratories currently 

certified to meet the standards of 

Subpart C of the Mandatory Guidelines 

for Federal Workplace Drug Testing 

Programs (Mandatory Guidelines). The 

Mandatory Guidelines were first 

published in the Federal Register on 

April 11, 1988 (53 FR 11970), and 

subsequently revised in the Federal 

Register on June 9, 1994 (59 FR 29908), 

on September 30, 1997 (62 FR 51118), 

and on April 13, 2004 (69 FR 19644). 

A notice listing all currently certified 

laboratories is published in the Federal 

Register during the first week of each 

month. If any laboratory’s certification 

mstockstill on PROD1PC66 with NOTICES